<DOC>
	<DOCNO>NCT00709124</DOCNO>
	<brief_summary>The purpose study investigate whether neuromuscular electrostimulation ( NMES ) decrease ICU-associated weakness . The investigator believe 60 minute daily NMES improve strength function extend ICU stay , well decrease critical illness myopathy etiology weakness critically ill .</brief_summary>
	<brief_title>Use Neuromuscular Electrostimulation ( NMES ) Treatment Prevention ICU-Associated Weakness</brief_title>
	<detailed_description>Survivors critical illness frequently significant , debilitate persistent weakness discharge intensive care unit ( ICU ) . This weakness persist 4 year ICU discharge . There intervention successful reduce prevent weakness . Neuromuscular electrostimulation ( NMES ) therapy beneficial population weak functionally limited patient , chronic respiratory failure require mechanical ventilation , severe chronic obstructive pulmonary disease end-stage congestive heart failure . We propose randomized clinical trial evaluate efficacy 60 minute NMES versus sham therapy , apply bilateral low extremity , reduce ICU-associated weakness patient acute respiratory failure . Our specific aim determine NMES therapy : 1 ) increase strength 3 treat low extremity muscle group ( i.e. , pretibial , triceps surae , quadriceps ) , 2 ) improve important clinical outcome ( i.e. , functional status , duration mechanical ventilation , length ICU hospital stay , in-hospital mortality , total hospital charge ) , 3 ) reduce critical illness myopathy etiology weakness clinically weak ICU patient . We hypothesize NMES therapy reduce ICU-associated weakness , improve clinical functional outcome . Additionally , rate critical illness myopathy etiology weakness clinically weak ICU patient lower receive NMES versus sham therapy . Since single test optimal measure muscle strength critically ill , employ four non-invasive measure : manual muscle test ( MMT ) , hand hold dynamometry ( HHD ) , handgrip dynamometry ( HGD ) , maximal inspiratory pressure ( MIP ) . With exist therapeutic option available , study explore potential NMES feasible intervention reduce ICU-associated weakness .</detailed_description>
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Paresis</mesh_term>
	<criteria>1 day mechanical ventilation expectation require ≥2 additional day ICU stay Johns Hopkins Intensive Care Unit ( ICU ) Unable understand speak English due language barrier cognitive impairment prior admission Unable independently transfer bed chair baseline prior hospital admission Known primary systemic neuromuscular disease ( e.g . GuillianBarre ) ICU admission Known intracranial process associate localize weakness ( e.g . cerebral vascular accident ) ICU admission Transferred another ICU outside Johns Hopkins system &gt; 4 consecutive day mechanical ventilation Moribund ( i.e . &gt; 90 % probability patient mortality next 96 hour ) Anticipated transfer another ICU care ( e.g . await organ transplantation transfer surgical ICU ) Any pacemaker ( e.g. , cardiac , diaphragm ) implant cardiac defibrillator Pregnancy Body mass index ≥35 kg/m2 Any limitation life support sole noCPR order Known suspect malignancy legs Unable treat evaluate low extremity ( e.g. , bilateral amputation , bilateral skin lesion ) ICU length stay &gt; 7 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Respiration , Artificial</keyword>
	<keyword>Critical Illness</keyword>
	<keyword>Intensive Care Units</keyword>
	<keyword>Electric Stimulation Therapy</keyword>
	<keyword>Muscle Weakness</keyword>
	<keyword>Paresis</keyword>
	<keyword>Mechanically</keyword>
	<keyword>Ventilated</keyword>
	<keyword>Patients</keyword>
	<keyword>Admitted</keyword>
	<keyword>Medical</keyword>
</DOC>